Avatar Medical, LLC

Avatar is a molecular engineering company that is developing novel universal Influenza and RSV subunit vaccines, both representing $ multi-billion market opportunities with mitigated clinical risk. Avatar Team: Chris Marshall

Read More

HemoGenyx, LLC

HemoGenyx is a preclinical-stage biotechnology company focused on the discovery, development and commercialisation of novel therapies and treatments for blood diseases, like leukemia and lymphoma. HemoGenyx Team: Vladislav Sandler

Read More

Parkside Scientific

New York City based Parkside Scientific develops novel “best-in-class” small molecule drugs that target bromodomain (BrD) proteins for epigenetic control of gene transcription in cancers and inflammatory disorders.   Parkside Scientific Team: Gary Duberstein

Read More

Lucerna, Inc.

At Lucerna, we are developing new sets of research tools to study and exploit RNA the same way fluorescent proteins did for the protein field. Lucerna Team: Karen Wu

Read More

Mirimus

Mirimus is engaged in the design, development and pioneering of new genome editing technologies to develop animal models that are crucial for the preclinical evaluation of new therapeutics. Mirimus Team: Prem Premsrirut    

Read More

CMP Scientific

CMP Scientific, Corp. is an analytical instrumentation company that provides capillary electrophoresis – mass spectrometry coupling interfaces to support therapeutics analysis for global biopharmaceutical companies. CMP Scientific Team: James Xia   CMP Scientific was with The Next Milestone at the Downstate Incubator from 2016 to 2017.

Read More

EpiBone, Inc.

We grow personalized living bone grafts in our lab, from patients own cells in the size and shape they need. EpiBone Team: Nina Tandon EpiBone has been with The Next Milestone at the Downstate Incubator since 2016.

Read More

Joint Innovations

We have developed a non-degradable synthetic implant designed to mechanically function in a similar way to the native tissue, while also enabling robust fixation at the site of implantation. Team: Suzanne Maher

Read More